✦ LIBER ✦
Safety, tolerability and immunogenicity of an immunotherapeutic vaccine (vanutide cridificar [ACC-001]) and the QS-21 adjuvant in Japanese individuals with mild-to-moderate Alzheimer's disease: A phase IIa, multicenter, randomized, adjuvant and placebo clinical trial
✍ Scribed by Arai, Heii; Suzuki, Hideo; Yoshiyama, Tamotsu; Lobello, Kasia; Peng, Yahong; Liu, Enchi; Ketter, Nzeera; Margolin, Richard; Jackson, Nicholas; Fujimoto, Yoko
- Book ID
- 122743427
- Publisher
- Elsevier Science
- Year
- 2013
- Tongue
- English
- Weight
- 53 KB
- Volume
- 9
- Category
- Article
- ISSN
- 1552-5260
No coin nor oath required. For personal study only.